DiaMedica Therapeutics Inc (DMAC)
2.63
+0.04
(+1.54%)
USD |
NASDAQ |
May 02, 16:00
2.61
-0.02
(-0.76%)
After-Hours: 20:00
DiaMedica Therapeutics Max Drawdown (5Y): 91.60% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 91.60% |
| March 31, 2024 | 91.60% |
| February 29, 2024 | 91.60% |
| January 31, 2024 | 91.60% |
| December 31, 2023 | 91.60% |
| November 30, 2023 | 91.60% |
| October 31, 2023 | 91.60% |
| September 30, 2023 | 91.60% |
| August 31, 2023 | 91.60% |
| July 31, 2023 | 91.60% |
| June 30, 2023 | 91.60% |
| May 31, 2023 | 91.60% |
| April 30, 2023 | 91.60% |
| March 31, 2023 | 91.60% |
| February 28, 2023 | 91.60% |
| January 31, 2023 | 91.60% |
| December 31, 2022 | 91.60% |
| November 30, 2022 | 91.60% |
| October 31, 2022 | 91.31% |
| September 30, 2022 | 91.08% |
| August 31, 2022 | 90.64% |
| July 31, 2022 | 90.64% |
| June 30, 2022 | 89.36% |
| May 31, 2022 | 90.51% |
| April 30, 2022 | 90.51% |
| Date | Value |
|---|---|
| March 31, 2022 | 90.51% |
| February 28, 2022 | 90.79% |
| January 31, 2022 | 90.79% |
| December 31, 2021 | 93.23% |
| November 30, 2021 | 94.84% |
| October 31, 2021 | 95.03% |
| September 30, 2021 | 95.03% |
| August 31, 2021 | 95.03% |
| July 31, 2021 | 95.03% |
| June 30, 2021 | 95.03% |
| May 31, 2021 | 95.03% |
| April 30, 2021 | 95.03% |
| March 31, 2021 | 95.03% |
| February 28, 2021 | 95.03% |
| January 31, 2021 | 95.03% |
| December 31, 2020 | 95.03% |
| November 30, 2020 | 95.06% |
| October 31, 2020 | 95.70% |
| September 30, 2020 | 96.70% |
| August 31, 2020 | 96.70% |
| July 31, 2020 | 96.70% |
| June 30, 2020 | 96.83% |
| May 31, 2020 | 97.51% |
| April 30, 2020 | 97.51% |
| March 31, 2020 | 97.51% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
89.36%
Minimum
Jun 2022
98.16%
Maximum
May 2019
93.96%
Average
94.93%
Median
Max Drawdown (5Y) Benchmarks
| NextCure Inc | -- |
| NovaBay Pharmaceuticals Inc | 99.91% |
| Palatin Technologies Inc | 96.46% |
| iBio Inc | 99.97% |
| Theriva Biologics Inc | 99.81% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -26.83 |
| Beta (5Y) | 1.754 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 92.23% |
| Historical Sharpe Ratio (5Y) | -0.0789 |
| Historical Sortino (5Y) | -0.1654 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 33.52% |